![](/static/media/logo.jpg)
An International Publisher for Academic and Scientific Journals
Author Login
Scholars Journal of Medical Case Reports | Volume-6 | Issue-02
The Association of a Perilimbic Injection of Anti-VEGF and Mitomycin C in the Treatment of Conjunctival Squamous Cell Carcinoma
Maha Bakhsh, Sara Belghmaidi, Ahmed Ghazza, Pr Ibtissam Hajji, Pr. Abdeljalil Moutaouakil
Published: Feb. 20, 2018 |
139
162
DOI: 10.36347/sjmcr.2018.v06i02.006
Pages: 83-86
Downloads
Abstract
Conjunctival Squamous Cell Carcinoma (Conjunctival SCC) and corneal intraepithelial neoplasia comprise what are called Ocular Surface Squamous Cell Neoplasias. .Conjunctival SCC is often asymptomatic at first, but it can present with the presence of a growth, red eye, pain, itching, burning, tearing, sensitivity to light, double vision, and decreased vision. Treatment of Conjunctival SCC is usually surgical excision followed by cryotherapy. Radiation treatment, topical Mitomycin C, and removal of the contents of the orbit, or exenteration, are other methods of treatment. We report this case to demonstrate the efficacy of an injection of perilimbic anti-VEGF (bevacizumab) combined with topical chemotherapy (mitomycin C) in the treatment of invasif SCC.